What is the translation of " IS INDICATED IN COMBINATION " in Slovenian?

• je indicirano v kombinaciji
• je indicirano skupaj

Examples of using Is indicated in combination in English and their translations into Slovenian

Zerit is indicated in combination with other antiretroviral medicinal products for the treatment of HIV infected patients.
Zdravilo Zerit je indicirano za zdravljenje bolnikov, okuženih s HIV, v kombinaciji z drugimi protiretrovirusnimi zdravili.

CellCept 500 mg powder for concentrate for solution for infusion is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal or hepatic transplants.
Zdravilo CellCept 500 mg prašek za koncentrat za raztopino za infundiranje je indicirano skupaj s ciklosporinom in kortikosteroidi za preprečevanje akutnih zavrnitvenih reakcij pri bolnikih z alogenim ledvičnim ali jetrnim presadkom.

Viread is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults over 18 years of age.
Viread je indiciran v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje odraslih oseb, starejših od 18 let, okuženih s HIV- 1.

Adult Patients(18 years of age or older): Ribavirin Mylan is indicated in combination with interferon alfa-2b, for the treatment of adult patients with all types of chronic hepatitis C except genotype 1, not previously treated without liver decompensation, with elevated alanine aminotransferase(ALT), who are positive for serum HCV-RNA(see section 4.4).
Odrasli bolniki(stari 18 let ali več): Zdravilo Ribavirin Mylan je indicirano v kombinaciji z interferonom alfa-2b za zdravljenje odraslih bolnikov z vsemi tipi kroničnih hepatitisov C, z izjemo genotipa 1, ki predhodno še niso bili zdravljeni, nimajo jetrne dekompenzacije, imajo zvišano vrednost alanin-aminotransferaze(ALT) in so pozitivni na serumsko RNA-HCV(glejte poglavje 4.4).

OLYSIO is indicated in combination with other medicinal products for the treatment of chronic hepatitis C(CHC) in adult patients(see sections 4.2, 4.4 and 5.1).
Zdravilo OLYSIO je indicirano v kombinaciji z drugimi zdravili za zdravljenje kroničnega hepatitisa C(CHC- chronic hepatitis C) pri odraslih bolnikih(glejte poglavja 4.2, 4.4 in 5.1).

Zydelig is indicated in combination with an anti-CD20 monoclonal antibody(rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia(CLL):.
Zdravilo Zydelig je indicirano v kombinaciji z monoklonskim protitelesom proti CD20(rituksimabom ali ofatumumabom) za zdravljenje odraslih bolnikov s kronično limfocitno levkemijo(KLL):.

Ribavirin Teva is indicated, in combination with peginterferon alfa-2b, for the treatment of adult patients with chronic hepatitis C who have failed previous treatment with interferon alpha.
Zdravilo Ribavirin Teva je indicirano v kombinaciji z interferonom alfa- 2b za zdravljenje odraslih bolnikov s kroničnim hepatitisom C, ki so se predhodno odzvali z normalizacijo.

Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Zdravilo Myfenax je indicirano skupaj s ciklosporinom in kortikosteroidi za preprečevanje akutnih zavrnitvenih reakcij pri bolnikih z alogenim ledvičnim, srčnim ali jetrnim presadkom.

Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants..
Myfenax je indiciran v kombinaciji s ciklosporinom in kortikosteroidi za profilakso akutne zavrnitve presadka pri bolnikih, ki so prejemali alogenske ledvične, srčne ali jetrne presaditve.

Mycophenolate mofetil Teva is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Zdravilo Mofetilmikofenolat Teva je indicirano skupaj s ciklosporinom in kortikosteroidi za preprečevanje akutnih zavrnitvenih reakcij pri bolnikih z alogenim ledvičnim, srčnim ali jetrnim presadkom.

Eucreas is indicated in combination with a sulphonylurea(i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.
Zdravilo Eucreas je indicirano v kombinaciji s sulfonilureo(torej kot del zdravljenja s trojno kombinacijo zdravil) poleg diete in telesne dejavnosti pri odraslih bolnikih, pri katerih diabetesa ni mogoče ustrezno urediti samo z metforminom in sulfonilureo.

Vargatef is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer(NSCLC) of adenocarcinoma tumour histology after first-line chemotherapy.
Zdravilo Vargatef je indicirano v kombinaciji z docetakselom za zdravljenje odraslih bolnikov z lokalno napredovalim, metastatskim ali lokalno ponovljivim nedrobnoceličnim pljučnim rakom(non-small cell lung cancer- NSCLC) s histologijo adenokarcinoma po kemoterapiji prve izbire.

Descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents(aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1(HIV-1)(see sections 4.2 and 5.1).
Zdravilo Descovy je indicirano v kombinaciji z drugimi protiretrovirusnimi učinkovinami za zdravljenje odraslih in mladostnikov(starih 12 let in več s telesno maso vsaj 35 kg), okuženih z virusom humane imunske pomanjkljivosti tipa 1(HIV-1)(glejte poglavji 4.2 in 5.1).

Janumet is indicated in combination with a sulphonylurea(i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.
Zdravilo Janumet je indicirano v kombinaciji s sulfonilsečnino(tj. trojno kombinirano zdravljenje) kot dodatek dieti in telesni aktivnosti pri bolnikih z neustrezno nadzorovano sladkorno boleznijo pri jemanju največjega odmerka metformina, ki ga prenašajo, in sulfonilsečnine.

Rebetol is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with chronic hepatitis C who have previously responded(with normalisation of ALT at the end of treatment) to interferon alpha monotherapy but who have subsequently relapsed.
Rebetol je indiciran v kombinaciji z interferonom alfa- 2b za zdravljenje odraslih bolnikov s kroničnim hepatitisom C, ki so se predhodno odzvali(z normalizacijo vrednosti ALT na koncu zdravljenja) na monoterapijo z interferonom alfa, a se je bolezen kasneje ponovila.

Lartruvo is indicated in combination with doxorubicin for the treatment of adult patients with advanced soft tissue sarcoma who are not amenable to curative treatment with surgery or radiotherapy and who have not been previously treated with doxorubicin(see section 5.1).
Terapevtske indikacije Zdravilo Lartruvo je indicirano v kombinaciji z doksorubicinom pri odraslih bolnikih z napredovalim sarkomom mehkih tkiv, ki jih ni mogoče učinkovito zdraviti z operacijo ali radioterapijo in ki z doksorubicinom še niso bili zdravljeni(glejte poglavje 5.1).

Rebetol is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with chronic hepatitis C, not previously treated, without liver decompensation, with elevated alanine aminotransferase(ALT), who are positive for serum HCV-RNA(see section 4.4).
Rebetol je indiciran v kombinaciji s interferonom alfa- 2b za zdravljenje odraslih bolnikov s kroničnim hepatitisom C, ki predhodno še niso bili zdravljeni, nimajo jetrne dekompenzacije, imajo zvišano vrednost alanin- aminotransferaze(ALT) in so pozitivni na serumsko HCV- RNA(glejte poglavje 4. 4).

Adult patients: Ribavirin Teva is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with chronic hepatitis C who have previously responded(with normalisation of ALT at the end of treatment) to interferon alpha monotherapy but who have subsequently relapsed.(see section 5.1).
Odrasli bolniki: Zdravilo Ribavirin Teva je indicirano v kombinaciji z interferonom alfa-2b za zdravljenje odraslih bolnikov s kroničnim hepatitisom C, ki so se predhodno odzvali(z normalizacijo vrednosti ALT na koncu zdravljenja) na monoterapijo z interferonom alfa, a se je bolezen kasneje ponovila(glejte poglavje 5.1).

Mozobil is indicated in combination with granulocyte-colony stimulating factor(G-CSF) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma and multiple myeloma whose cells mobilise poorly(see section 4.2).
Zdravilo Mozobil je indicirano v kombinaciji z granulocitne kolonije stimulirajočim faktorjem(G-CSF- granulocyte-colony stimulating factor) za pospeševanje mobilizacije krvotvornih matičnih celic v periferno kri, za zbiranje in kasnejšo avtologno presaditev pri odraslih bolnikih z limfomom in multiplim mielomom, ki imajo nezadostno mobilizacijo celic(glejte poglavje 4.2).

Adult patients: Ribavirin Teva is indicated, in combination with interferon alfa-2b, for the treatment of adult patients with all types of chronic hepatitis C except genotype 1, not previously treated, without liver decompensation, with elevated alanine aminotransferase(ALT), who are positive for hepatitis C viral ribonucleic acid HCV-RNA(see section 4.4).
Odrasli bolniki: Zdravilo Ribavirin Teva je indicirano v kombinaciji s interferonom alfa-2b za zdravljenje odraslih bolnikov z vsemi tipi kroničnega hepatitisa C, razen genotipa 1, ki predhodno še niso bili zdravljeni, nimajo jetrne dekompenzacije, imajo zvišano vrednost alanin-aminotransferaze(ALT) in so pozitivni na ribonukleinsko kislino virusa hepatitisa C RNA-HCV(glejte poglavje 4.4).

Viread 245 mg film-coated tablets are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults.
Zdravilo Viread 245 mg filmsko obložene tablete je indicirano v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje odraslih, okuženih s HIV-1.

Viread 123 mg film-coated tablets are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients, with NRTI resistance or toxicities precluding the use of first line agents, aged 6 to< 12 years who weigh from 17 kg to less than 22 kg.
Zdravilo Viread 123 mg filmsko obložene tablete je indicirano v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje pediatričnih bolnikov, okuženih s HIV-1, odpornih na NRTI ali s toksičnostjo, ki onemogoča uporabo zdravil prve izbire, starih 6 do< 12 let, s telesno maso 17 kg do manj kot 22 kg.

Viread 33 mg/g granules are indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients, with NRTI resistance or toxicities precluding the use of first line agents, from 2 to< 6 years of age, and above 6 years of age for whom a solid dosage form is not appropriate.
Zdravilo Viread 33 mg/g zrnca je indicirano v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje pediatričnih bolnikov, okuženih s HIV-1, odpornih na NRTI ali s toksičnostjo, ki onemogoča uporabo zdravil prve izbire, starih 2 do< 6 let, in starih več kot 6 let, pri katerih ni mogoče uporabiti trdne farmacevtske oblike.